| Issue |
Title |
File |
| Vol 2, No 4 (2021) |
Plasma levels of neurotrophic factors are not associated with the severity of depression |
(Eng)
|
|
Zorkina Y.A., Syunyakov T.S., Abramova O.V., Yunes R.A., Pavlichenko A.V., Pavlov K.A., Khobta E.B., Susloparova D.A., Tsarapkin G.Y., Andreyuk D.S., Danilenko V.N., Gurina O.I., Morozova A.Y.
|
| Vol 2, No 3 (2021) |
Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia |
(Eng)
|
|
Tkachev A.I., Stekolshchikova E.A., Morozova A.Y., Anikanov N.A., Zorkina Y.A., Alekseyeva P.N., Khobta E.B., Andreyuk D.S., Zozulya S.A., Barkhatova A.N., Klyushnik T.P., Reznik A.M., Kostyuk G.P., Khaitovich P.E.
|
| Vol 2, No 3 (2021) |
Clinical Features of First-episode Psychoses During the COVID-19 Pandemic |
(Eng)
|
|
Zyablov V.A., Gusev M.A., Chizhikov V.S.
|
| Vol 2, No 3 (2021) |
Revisiting Drug Compliance: The Need for a Holistic Approach in the Treatment of Severe Mental Disorders |
(Eng)
|
|
Sorokin M.Y., Neznanov N.G., Lutova N.B., Wied V.D.
|
| Vol 2, No 2 (2021) |
Toward ICD-11 Implementation: Attitudes and Expectations of the Russian Psychiatric Community |
(Eng)
|
|
Kulygina M.A., Syunyakov T.S., Fedotov I.A., Kostyuk G.P.
|
| Vol 2, No 2 (2021) |
The Use of ICD-10 for Diagnosing Mental Disorders In Russia, According to National Statistics and a Survey of Psychiatrists' Experience |
(Eng)
|
|
Martynikhin I.A.
|
| Vol 2, No 1 (2021) |
Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia |
(Eng)
|
|
Malashenkova I.K., Krynskiy S.A., Ogurtsov D.P., Hailov N.A., Zakharova N.V., Bravve L.V., Kaydan M.A., Chekulaeva E.I., Andreyuk D.S., Ushakov V.L., Didkovsky N.A., Kostyuk G.P.
|
| Vol 2, No 1 (2021) |
Suicides in the COVID-19 Pandemic — Are We Well Informed Regarding Current Risks and Future Prospects? |
(Eng)
|
|
Rozanov V.A., Semenova N.V., Vuks A.J., Freize V.V., Isakov V.D., Yagmurov O.D., Neznanov N.G.
|
| Vol 2, No 1 (2021) |
Emotional Response to Humour Perception and Gelotophobia Among Healthy Individuals and Patients with Schizophrenia and Depression, with Signs of a High Clinical Risk of Psychosis |
(Eng)
|
|
Volovik D.D., Omelchenko M.A., Ivanova A.M.
|
| Vol 1, No 1 (2020) |
Impact of COVID-19 pandemic on anxiety, depression and distress – online survey results amid the pandemic in Russia |
(Eng)
|
|
Karpenko O.A., Syunyakov T.S., Kulygina M.A., Pavlichenko A.V., Chetkina A.S., Andrushchenko A.V.
|
| Vol 1, No 1 (2020) |
Schizophrenia and toxoplasmosis: association with catatonic symptoms |
(Eng)
|
|
Romanov D.V., Brazhnikov A.I., Andreyuk D.S., Zakharova N.V., Bravve L.V., Kovaleva V.A., Abbazova E.V., Goncharov D.B., Titova I.V., Domonova E.A., Kostyuk G.P.
|
| 1 - 11 of 11 Items |
|
